Integral Health Asset Management, LLC Seagen Inc. Transaction History

Integral Health Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$108.81 - $179.33 $2.03 Million - $3.35 Million	-18,689 Reduced 37.38%	31,311 $5.54 Million
Q1 2022 May 12, 2022	BUY	$119.61 - $157.85 $5.98 Million - $7.89 Million	50,000 New	50,000 $7.2 Million
Q4 2021 Feb 02, 2022	SELL	$142.57 - $190.86 $5.7 Million - $7.63 Million	-40,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$142.45 - $169.82 $5.7 Million - $6.79 Million	40,000 New	40,000 $6.79 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.